|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C07K 16/22 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| C12N 15/13 | (2006.01) | ||
| A61P 5/06 | (2006.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 2559705 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12154124.7 |
| Date of filing the European patent application | 2007-09-07 | |
| (97) | Date of publication of the European application | 2013-02-20 |
| (45) | Date of publication and mention of the grant of the patent | 2016-07-13 |
| (46) | Date of publication of the claims translation | 2016-10-25 |
| (30) | Number | Date | Country code |
| 843430 P | 2006-09-08 | US | |
| 956653 P | 2007-08-17 | US |
| (72) |
Han, Hq, US
Chen, Qing, US
Kwak, Keith, Soo-Nyung, US
Zhou, Xiaolan, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
| (54) | Antikūnai prieš aktiviną A ir jų naudojimai |
| Anti-activin a antibodies and uses thereof |
| Payment date | Validity (years) | Amount | |
| 2022-08-18 | 16 | 347.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2022-07-07 |